WCLC 2024
Sep 20, 2024
Post WCLC 2024 Insights: Recent Advancements in Thoracic Malignancies
NSCLC is the most common type of lung cancer accounting for approximately 85% of all lung cancers (roughly 509,000 incident cases in 2019 [7MM: the US, EU4 and the UK, and Japan]). The real-world treatment trend depicts a significant shift towards targeted and immunotherapies (from only systemic therapies in the pa...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
